In a new study, researchers from research institutions such as the University of Washington in the United States studied monoclonal antibodies which were isolated from survivors of the severe acute respiratory syndrome (SARS) or Middle East Respiratory Syndrome (MERS) caused by the coronavirus. These monoclonal antibodies reveal an alarming immune defense strategy against deadly viruses. Atomic and molecular information for these highly potent antibodies may provide new insights into these…